| Year | 2025 |
|---|---|
| Authors | PING-HSUN CHEN |
| Paper Title | Ping-Hsun Chen*, 2025.10, 'How a Treatment Claim Without Reciting Safety and Efficacy Requirements May Survive the Disclosure Requirement Challenge: United Therapeutics Corp. v. Liquidia Technologies, Inc., ' Biotechnology Law Report, Vol.44, No.5, pp.279–280.(SCIE)(*為通訊作者) |
| Vol.No | 143181 |
| Date of Publication | 2025-10-01 |
Login NCCU College of Commerce
